1 option
Glycopeptide-resistant enterococci / Dr. Neil Woodford.
- Format:
- Video
- Author/Creator:
- Woodford, Neil, author.
- Series:
- Henry Stewart talks
- Language:
- English
- Subjects (All):
- Enterococcus.
- Physical Description:
- 1 videorecording (40 min., 32 sec.) : sound, color.
- Place of Publication:
- London : Henry Stewart Talks Ltd, [2009]
- System Details:
- video file
- Contents:
- Introduction
- GRE: where it all began
- Prevalence of GRE in the UK
- GRE bacteraemias, EARSS 2008
- Vancomycin resistant enterococci in the US
- GRE are a localised problem in the UK
- Enterococci as opportunist pathogens
- Risk factors for GRE infection
- The clinical problem with GRE - mutliresistance
- Enterococcus species
- Glycopeptide resistance in enterococci
- Characteristics of glycopeptide resistance
- GRE: primarily E. faecium with VanA
- Glycopeptide action and resistance
- GRE ... all because of one critical H-bond
- Regulation of glycopeptide resistance (VanA)
- Cell wall synthesis in GRE
- Glycopeptide dependent enterococci
- Cell wall synthesis in resistant enterococci
- Resistant isolates
- PFGE analysis: the "gold standard" method
- A national epidemic of GRE in the UK?
- Avoparcin and VanA resistance
- MLST of 720 E. faecium isolates
- Hospital-adapted lineages
- Virulence of E. faecalis
- Resistance genes and elements
- Genetic exchange in enterococci
- The van gene clusters of enterococci
- Transposons carry van gene clusters
- A national epidemic of VanA elements?
- VanA elements in the UK
- Origins of resistant enterococci affecting humans
- Diversity among VanA elements
- Transfer of van genes beyond enterococci
- VanA MRSA has arrived
- Glycopeptide MICs for two VRSA strains
- Poor detection of some VRSA
- Glycopeptide-intermediate S. aureus (GISA)
- Biochemical basis of resistance in GISA
- Resistance to new agents: the red queen theory
- Quinupristin-dalfopristin vs. enterococci
- 'Q-D' resistance mechanisms in enterococci
- Linezolid resistance in enterococci
- Development of linezolid resistance
- Linezolid resistance - summary
- Daptomycin: a cyclic lipopeptide
- Daptomycin: mechanism of action
- Daptomycin: resistance issues, E. faecium
- Second generation glycopeptides (1)
- Vancomycin's and teicoplanin's modes of action
- Second generation glycopeptides (2)
- In vitro activity vs. enterococci
- Telavancin vs. GRE
- Potential for a better anti GRE glycopeptide
- Epidemiology of GRE
- Acknowledgements.
- Notes:
- Description based on publisher supplied metadata and other sources.
- Retrieved April 14, 2024, from https://hstalks.com/bs/1539/.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.